Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1

Anne Slavotinek1, Heather Pua2, Ugur Hodoglugil3

  • 1Division of Medical Genetics, Department of Pediatrics, UCSF, San Francisco, CA 94143-2711, USA.

Insights

A novel TBL1XR1 gene mutation, p.Tyr446Cys, is linked to Pierpont syndrome in a young male with severe developmental delays and distinctive features. This specific mutation causes a recognizable syndromic intellectual disability, unlike other TBL1XR1 variants.

Area of Science:

  • Genetics
  • Developmental Biology
  • Medical Genetics

Background:

  • Pierpont syndrome is a rare genetic disorder characterized by developmental delays, hypotonia, and distinctive facial and digital features.
  • Mutations in the TBL1XR1 gene have been associated with intellectual disability and autism spectrum disorder.

Observation:

  • A 7-year-old male presented with severe developmental delays, hypotonia, dysmorphic features, deep palmar/plantar creases, and soft tissue "pillowing" of hands and feet.
  • Facial features included a high hairline, small eyes, bulbous nasal tip, large mouth, and small chin. He also had a submucous cleft palate, bilateral cryptorchidism, and hydronephrosis.
  • Cranial imaging revealed an Arnold-Chiari malformation.

Findings:

  • Exome sequencing identified a de novo heterozygous variant, p.Tyr446Cys, in the TBL1XR1 gene, previously reported in Pierpont syndrome.
  • This mutation is located in the carboxy-terminal WD40 domain, potentially affecting interactions with co-repressor complexes and chromatin.
  • The patient exhibited submucous cleft palate and hydronephrosis, features not previously reported with this specific TBL1XR1 mutation.

Implications:

  • The p.Tyr446Cys variant in TBL1XR1 appears to cause a clinically recognizable syndromic form of intellectual disability, distinct from other TBL1XR1 mutations.
  • This case expands the phenotypic spectrum associated with TBL1XR1 mutations, highlighting mutation-specific pathogenic mechanisms.
  • Understanding these genotype-phenotype correlations is crucial for accurate diagnosis and potential therapeutic strategies for Pierpont syndrome and related disorders.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
158.2K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
19.6K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.6K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
51
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
16.3K
Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
50.6K